Skip to main content
. Author manuscript; available in PMC: 2008 Feb 4.
Published in final edited form as: Neuropharmacology. 2005 Feb 19;48(8):1130–1138. doi: 10.1016/j.neuropharm.2004.12.005

Fig. 4.

Fig. 4

Representative recordings of the effects of anandamide (10 mg/kg i.v., AEA; panel A) and the FAAH antagonist URB597 (10 mg/kg i.v.; panel B) on blood pressure in normotensive (left column) and in angiotensine II-induced hypertensive (right column) anesthetized rats, and reversal (panel B left) or prevention (panel C) of the hypotensive effects of URB597 in hypertensive rats by the CB1 antagonist AM251. The arrows indicate the injection of the drugs.